The relationship between depression and physical symptom burden in advanced cancer

BMJ Supportive and Palliative Care

Volumn 5, Issue 4, 2015, Pages 381-388

  Fitzgerald, Peter ^a,b   Lo, Chris ^a,b   Li, Madeline ^a,b   Gagliese, Lucia ^a,c,d   Zimmermann, Camilla ^a,e   Rodin, Gary ^a,b  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY HEALTH NETWORK   (Canada)

^d YORK UNIVERSITY   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; COMPLICATION; CROSS-SECTIONAL STUDY; DEPRESSION; FATIGUE; FEMALE; HUMAN; KARNOFSKY PERFORMANCE STATUS; MALE; MENTAL HEALTH; MIDDLE AGED; NEOPLASM; PAIN; SURVIVAL ANALYSIS;

AGED; CROSS-SECTIONAL STUDIES; DEPRESSION; FATIGUE; FEMALE; HUMANS; KARNOFSKY PERFORMANCE STATUS; MALE; MENTAL STATUS SCHEDULE; MIDDLE AGED; NEOPLASMS; PAIN; SURVIVAL ANALYSIS;

EID: 84947943028     PISSN: 2045435X     EISSN: 20454368     Source Type: Journal    
DOI: 10.1136/bmjspcare-2012-000380     Document Type: Article

References (39)

1. Teunissen SCCM, Wesker W, Kruitwagen C, et al. Symptom prevalence in patients with incurable cancer: a systematic review. J Pain Symptom Manage 2007;34:94-104.
2. Walsh D, Donnelly S, Rybicki L. The symptoms of advanced cancer: relationship to age, gender, and performance status in 1,000 patients. Support Care Cancer 2000;8:175-9.
3. Gilbertson-White S, Aouizerat BE, Jahan T, et al. A review of the literature on multiple symptoms, their predictors, and associated outcomes in patients with advanced cancer. Palliat Support Care 2011;9:81-102.
4. Ferreira KASL, Kimura M, Teixeira MJ, et al. Impact of cancer-related symptom synergisms on health-related quality of life and performance status. J Pain Symptom Manage 2008;35:604-16.
5. Rodin G, Lo C, Mikulincer M, et al. Pathways to distress: the multiple determinants of depression, hopelessness and the desire for hastened death in metastatic cancer patients. Soc Sci Med 2009;68:562-9.
6. Lo C, Zimmermann C, Rydall A, et al. Longitudinal study of depressive symptoms in patients with metastatic gastrointestinal and lung cancer. J Clin Oncol 2010;28:3084-9.
7. Irving G, Lloyd-Williams M. Depression in advanced cancer. Eur J Oncol Nurs 2010;14:395-9.
8. Grassi L, Indelli M, Marzola M, et al. Depressive symptoms and quality of life in home-care-assisted cancer patients. J Pain Symptom Manage 1996;12:300-7.
9. Watson D, Pennebaker JW. Health complaints, stress, and distress: exploring the central role of negative affectivity. Psychol Rev 1989;96:234-54.
10. Costa PT Jr, McCrae RR. Neuroticism, somatic complaints, and disease: is the bark worse than the bite? J Pers 1987;55:299-316.
11. Howren MB, Suls J, Martin R. Depressive symptomatology, rather than neuroticism, predicts inflated physical symptom reports in community-residing women. Psychosom Med 2009;71:951-7.
12. Howren MB, Suls J. The symptom perception hypothesis revised: depression and anxiety play different roles in concurrent and retrospective physical symptom reporting. J Pers Soc Psychol 2011;100:182-95.
13. Li M, Rodin G. Depression. In: Levenson JL, ed. Textbook of Psychosomatic Medicine: Psychiatric Care of the Medically Ill 2nd Edition. Arlington, VA: American Psychiatric Publishing, 2011:175-97.
14. Barsky AJ, Goodson JD, Lane RS, et al. The amplification of somatic symptoms. Psychosom Med 1988;50:510-19.
15. Laird BJA, Boyd AC, Colvin LA, et al. Are cancer pain and depression interdependent? A systematic review. Psycho-Oncology 2009;18:459-64.
16. Brown LF, Kroenke K. Cancer-related fatigue and its associations with depression and anxiety: a systematic review. Psychosomatics 2009;50:440-47.
17. O'Connor M, Weir J, Butcher I, et al. Pain in patients attending a specialist cancer service: prevalence and association with emotional distress. J Pain Symptom Manage 2012;43:29-38.
18. Gaston-Johansson F, Fall-Dickson JM, Bakos AB, et al. Fatigue, pain, and depression in pre-autotransplant breast cancer patients. Cancer Pract 1999;7:240-7.
19. Steel JL, Kim KH, Dew MA, et al. Cancer-related symptom clusters, eosinophils, and survival in hepatobiliary cancer: an exploratory study. J Pain Symptom Manage 2010;39:859-71.
20. Laird BJA, Scott AC, Colvin LA, et al. Pain, depression, and fatigue as a symptom cluster in advanced cancer. J Pain Symptom Manage 2011;42:1-11.
21. Katon W, Lin EHB, Kroenke K. The association of depression and anxiety with medical symptom burden in patients with chronic medical illness. Gen Hosp Psych 2007;29:147-55.
22. Chen ML, Chang HK. Physical symptom profiles of depressed and nondepressed patients with cancer. Palliative Medicine 2004;18:712-18.
23. Lloyd-Williams M, Dennis M, Taylor F. A prospective study to determine the association between physical symptoms and depression in patients with advanced cancer. Palliative Medicine 2004;18:558-63.
24. Delgado-Guay M, Parsons HA, Li Z, et al. Symptom distress in advanced cancer patients with anxiety and depression in the palliative care setting. Support Care Cancer 2009;17:573-9.
25. Portenoy RK, Thaler HT, Kornblith AB, et al. The memorial symptom assessment scale: an instrument for the evaluation of symptom prevalence, characteristics and distress. Eur J Cancer 1994;30A:1326-36.
26. Karnofsky D, Burchenal JH. The clinical evaluation of chemotherapeutic agents in cancer. In: Macleod CM, ed. Evaluation of Chemotherapeutic Agents. New York, NY: Columbia University, 1949:191-205.
27. Beck AT, Steer RA, Brown GK. Manual for the Beck Depression Inventory-II. San Antonio, TX: Psychological Corporation, 1996.
28. Berard RMF, Boermeester F, Viljoen G. Depressive disorders in an outpatient oncology setting: prevalence, assessment, and management. Psycho-oncology 1998;7:112-20.
29. Warmenhoven F, van Rijswijk E, Engels Y, et al. The beck depression Inventory (BDI-II) and a single screening question as screening tools for depressive disorder in Dutch advanced cancer patients. Support Care Cancer 2012;20:319-24.
30. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders Text Revision (DSM-IV TR) 4th edition. Washington, DC: American Psychiatric Association Press, 2000.
31. Miller AH, Ancoli-Israel S, Bower JE, et al. Neuroendocrineimmune mechanisms of behavioural comorbidities in patients with cancer. J ClinOncol 2008;26:971-82.
32. Li M, Soczynska JK, Kennedy SH. Inflammatory biomarkers in depression: an opportunity for novel therapeutic interventions. Curr Psychiatry Rep 2011;13:316-20.
33. Aronson KR, Barrett LF, Quigley K. Emotional reactivity and the overreport of somatic symptoms: somatic sensitivity or negative reporting style? J Psychosom Res 2006;60:521-30.
34. Gendolla GH, Abele AE, Andrei A, et al. Negative mood, self-focused attention, and the experience of physical symptoms: the joint impact hypothesis. Emotion 2005;5:131-44.
35. Nolen-Hoeksema S, Wisco BE, Lyubomirsky S. Rethinking rumination. Perspect Psychol Sci 2008;3:400-24.
36. Clark D. 'Total pain', disciplinary power and the body in the work of Cicely Saunders, 1958-1967. Social Sci Med 1999;49:727-36.
37. Given C, Given B, Rahbar M, et al. Effect of a cognitive behavioural intervention on reducing symptom severity during chemotherapy. J Clin Oncol, 2004;22:507-16.
38. Sheinfeld Gorin S, Krebs P, Badr H, et al. Meta-analysis of psychosocial interventions to reduce pain in patients with cancer. J Clin Oncol 2012;30:539-47.
39. Goodwin L, Lee W, Price A, et al. Predictors of non-remission of depression in a palliative care population. Palliat Med 2012;26:683-95.